Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts

Blood

Volumn 87, Issue 9, 1996, Pages 3749-3757

  Hagood, James S ^a   Olman, Mitchell A ^b   Godoy, Juan A ^b   Rivera, Kimberly E ^b   Fuller, Gerald M ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN DEGRADATION PRODUCT; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL CELL; ARTICLE; FIBRIN DEPOSITION; FIBRINOLYSIS; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RNA ANALYSIS;

EID: 0029923239     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3749.bloodjournal8793749     Document Type: Article

References (64)

1. Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J: Regulation of extravascular coagulation by microvascular permeability. Science 227:1059, 1985
2. Dvorak HF: Tumors: Wounds that do not heal. N Engl J Med 315:1650, 1986
3. Colvin RB, Dvorak HF: Role of the clotting system in cell-mediated immunity. J Immunol 114:377, 1975
4. Saksela O, Rifkin DB. Cell-associated plasminogen activation: Regulation and physiological functions. Annu Rev Cell Biol 4:93, 1988
5. Loskutoff DJ, Sawdey M, Mimuro J: Type 1 plasminogen activator inhibitor, in Coller BS (ed): Progress in Hemostasis and Thrombosis, vol 9. Philadelphia, PA, Saunders, 1989, p 87
6. Brown LF, Dvorak AM, Dvorak HF: Leaky vessels, fibrin deposition, and fibrosis: A sequence of events common to solid tumors and to many other types of disease. Am Rev Respir Dis 140:1104, 1989
7. Crouch E: Pathobiology of pulmonary fibrosis. Am J Physiol 259:L159, 1990
8. Olman M, Mackman N, Gladson C, Moser K, Loskutoff D: Changes in procoagulant and fibrinolytic gene expression during Bleomycin induced lung injury in the mouse. J Clin Invest 96:1621, 1995
9. Kuhn C, Boldt J, King TE, Crouch E, Vartio T, McDonald JA: An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140:1693, 1989
10. Crystal RG, Ferrans VJ, Basset F: Biologic basis of pulmonary fibrosis, in Crystal RG (ed): The Lung. New York, NY, Raven, 1991, p 2031
11. Gillery P, Bellon G, Coustry F, Borel J-P: Cultures of fibroblasts in fibrin lattices: Models for the study of metabolic activites of the cell in physiological conditions. J Cell Physiol 140:483, 1989
12. Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF: Fibroblast migration in fibrin gel matrices. Am J Pathol 142:273, 1993
13. Altieri DC: Coagulation assembly on leukocytes in transmembrane signalling and cell adhesion. Blood 81:569, 1993
14. Gray AJ, Bishop JE, Reeves JT, Mecham RP, Laurent GJ: Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 12:684, 1995
15. Danielson PE, Forss-Petter S, Brow MA, Calvetta L, Douglass J, Milner RJ, Sutcliffe JG: p1B15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261, 1988
16. Wang Y, Fuller GM: The putative role of fibrin fragments in the biosynthesis of fibrinogen by hepatoma cells. Biochem Biophys Res Commun 175:562, 1991
17. Fuller GM, Otto JM, Woloski BM, McGary CT, Adams MA: The effects of hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers. J Cell Biol 101:1481, 1985
18. McIntosh JC, Hagood JS, Richardson TL, Simecka JW: Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats. Eur Respir J 7:2131, 1994
19. Fuller GM, Bunzel RJ, Nesbitt JE: Fibrinogen. Methods Enzymol 163:474, 1988
20. Deutsch DG, Mertz ET: Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095, 1970
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
22. Rabilloud T, Carpentier G, Tarroux P: Improvement and simplification of low-background silver staining of proteins by using sodium dithionite. Electrophoresis 9:288, 1988
23. Ferguson EW, Fretto LJ, McKee PA: A re-examination of the cleavage of fibrinogen and fibrin by plasmin. J Biol Chem 250:7210, 1975
24. Rajagopalan S, Pizzo SV: Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products. Blood 67.1224, 1986
25. Chen JP, Shurley HM, Vickrey MF: A facile separation of fragments D and E from the fibrinogen/fibrin degradation products of three mammalian species. Biochem Biophys Res Commun 61:66, 1974
26. Scherrer K, Darnell JE: Sedimentation characteristics of rapidly labelled RNA from HeLa cells. Biochem Biophys Res Commun 7:486, 1962
27. Johnston RJ, Pickett SC, Baker DL: Autoradiography using storage phosphor technology. Electrophoresis 11:355, 1990
28. Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR: Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 86:1241, 1992
29. Erickson LA, Lawrence DA, Loskutoff DJ: Reverse fibrin autography; a method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem 137:454, 1984
30. Vassali JD, Belin D: Amiloride selectively inhibits the urokinase-like plasminogen activator. FEBS Lett 214:187, 1987
31. Zar GH: Biostatistical Analysis (ed 2). Englewood Cliffs, NJ, Prentice-Hall, 1984
32. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ, Postlethwaite AE, Kang AH, Moses HL: Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin and type I procollagen by transforming growth factor-β. J Biol Chem 263:3111, 1988
33. Senior RM, Skogen WF, Griffin GL, Wilner GD: Effects of fibrinogen derivatives upon the inflammatory response. J Clin Invest 77:1014, 1986
34. Ito Y, Liu S-Q, Nakabayashi M, Imanishi Y: Cell growth on immobilized cell-growth factor. Biomaterials 13:789, 1992
35. Knox P, Crooks S, Scaife MC, Patel S: Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots. J Cell Physiol 132:501, 1987
36. Michel D, Harmand MF: Fibrin seal in wound healing: Effect of thrombin and (Ca2+) on human skin fibroblast growth and collagen production. J Dermatol Sci 1:325, 1990
37. Mirshahi M, Azzarone B, Soria J, Mirshahi F, Soria C: The role of fibroblasts in organization and degradation of a fibrin clot. J Lab Clin Med 117:274, 1991
38. 2 and matrix metalloproteinases. J Biol Chem 270:10365, 1995
39. Tremble P, Chiquet-Ehrismann R, Werb Z: The extracellular matrix lieands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 5:439, 1994
40. Robson SC, Shephard EP, Kirsch RE: Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1β, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86:322, 1994
41. Ge M, Tang G, Ryan TJ, Malik AB: Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J Clin Invest 90:2508, 1992
42. Hamaguchi M, Morishita Y, Takahashi I, Ogura M, Takamatsu J, Saito H: FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. Blood 77:94, 1991
43. Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G: Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-β and TNF-α. Am J Physiol 263:L487, 1992
44. Thalacker FW, Nilsen-Hamilton M: Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type I plasminogen activator inhibitor expression. Biochem J 287:855, 1992
45. Francis CW, Marder VJ, Barlow GH: Plasmic degradation of crosslinked fibrin. J Clin Invest 66:1033, 1980
46. Hatzfeld JA, Hatzfeld A, Maigne J: Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. Proc Natl Acad Sci USA 79:6280, 1982
47. Dang CV, Bell WR, Kaiser D, Wong A: Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. Science 227:1487, 1985
48. Ge M, Ryan TJ, Lum H, Malik AB: Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol 261:L283, 1991
49. Robson SC, Saunders R, Purves LR, Jager Cd, Corrigall A, Kirsch RE: Fibrin and fibrinogen degradation products with an intact D-domain C-terminal γ chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis. Blood 81:3006, 1993
50. Haynes JB, Hyers TM, Giclas PC, Franks JJ, Petty TL: Elevated fibrin(ogen) degradation products in the adult respiratory distress syndrome. Am Rev Respir Dis 122:841, 1980
51. Manwaring D, Thorning D, Curreri PW: Mechanisms of acute pulmonary dysfunction induced by fibrinogen degradation product D. Surgery 84:45, 1978
52. Luterman A, Manwaring D, Curreri PW: The role of fibrinogen degradation products in the pathogenesis of respiratory distress syndrome. Surgery 82:703, 1977
53. Dejana L, Vergara-Dauden M, Balconi G, Pietra A, Cherel G, Donati MB, Lameu M-J, Maruerie G: Specific binding of human fibrinogen to cultured fibroblasts. J Biochem 139:657, 1984
54. Stirk CM, Kochhar A, Smith EB, Thompson WD: Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques. Atherosclerosis 103:159, 1993
55. Felding-Habermann B, Ruggeri ZM, Cheresh DA: Distinct biological consequences of integrin αvβ3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 267:5070, 1992
56. Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR: Structural recognition of a novel fibrinogen γ chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 270:696, 1995
57. Barsigian C, Fellin FM, Jain A, Martinez J: Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-linking at the hepatocyte surface. J Biol Chem 263:14015, 1988
58. Levesque J-P, Hatzfeld J, Hatzfeld A: A mitogenic fibrinogen receptor that differs from glycoprotein IIb-IIIa. J Biol Chem 265:328, 1990
59. Curtis D, Lehmann R, Zamore PD: Translational regulation in development. Cell 81:171, 1995
60. Kaminski M, MacDonagh J: Studies on the mechanism of thrombin: Interaction with fibrin. J Biol Chem 258:10530, 1983
61. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA: Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890, 1990
62. Chapman HA, Allen CL, Stone QL: Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am J Respir Cell Mol Biol 133:437, 1986
63. Nakstad B, Lyberg T, Skjonsberg OH, Boye NP: Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 57:827, 1990
64. Viscardi RM, Broderick K, Sun C-C, Yale-Loehr AJ, Hessamfar A, Taciak V, Burke KC, Koenig KB, Idell S: Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am Rev Respir Dis 146:492, 1992